In conclusion, we observed an altered profile of circulating peptides regulating appetite—especially nesfatin-1 and spexin—in non-obese children with Prader-Willi syndrome during growth hormone treatment and reduced energy intake. Here, SPX is linked to Prader-Willi syndrome.